CNAP HD SIGNED
Continuous Non-invasive diagnosis of Arterial Pressure and Hemodynamics
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0CNAP HD project word cloud
Explore the words cloud of the CNAP HD project. It provides you a very rough idea of what is the project "CNAP HD" about.
Project "CNAP HD" data sheet
The following table provides information about the project.
| Coordinator |
CNSYSTEMS MEDIZINTECHNIK AG
Organization address contact info |
| Coordinator Country | Austria [AT] |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3.1. (SOCIETAL CHALLENGES - Health, demographic change and well-being) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) |
| Code Call | H2020-SMEINST-1-2014 |
| Funding Scheme | /SME-1 |
| Starting year | 2015 |
| Duration (year-month-day) | from 2015-05-01 to 2015-09-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | CNSYSTEMS MEDIZINTECHNIK AG | AT (GRAZ) | coordinator | 50˙000.00 |
Mappa
Project objective
CNSystems' CNAP HD technology is an innovative diagnostic tool for a significant reduction of peri- and postoperative complications resulting in an enhanced recovery after surgery. Consequently, the use of CNAP HD reduces length of hospital stay and decreases costs substantially. The planned diagnostic devices CNAP HD integral and CNAP HD connect are designed for the continuous non-invasive or minimal-invasive measurement of hemodynamic (HD) parameters. These parameters are biomarkers, which classify as “measurable diagnostic indicators that are used to assess the risk or presence of disease”.
CNAP HD integral / connect will be used for diagnosing HD. It will guide intravenous fluid and inotropic therapy by achieving goals for cardiac output (CO) and other dynamic biomarkers in order to optimize the balance between oxygen supply and demand. Keeping the patient's fluid status in balance is the most effective way to combat complications such as infections, global tissue hypoxia, shock and multi organ failure.
Medical outcome of the new diagnostic method is impressive: if HD is optimised by CNAP HD, overall complication rate will be reduced by 34% (from 83% in a group with standard treatment to 55% in HD-optimised patients) and infections will decrease by 61% (from 57% in standard treatment to 22%). CNAP HD has further proven clinical accuracy shown in various validation, application and outcome studies.
The greatest impact regarding cost savings will be achieved in medium to high-risk surgeries and/or in medium to high-risk patients. Elderly patients with existing co-morbidities will benefit most. The annual cost savings potential for Europe with its age structure is ∼ €2.6 billion.
For its broad rollout, the technology has to fulfil usability needs of anaesthesiologists working in OR's. For that a vast innovation thrust is planned. The current proposal describes how CNSystems wants to successfully design its new diagnostic devices CNAP HD integral / connect.
Work performed, outcomes and results: advancements report(s)
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CNAP HD" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CNAP HD" are provided by the European Opendata Portal: CORDIS opendata.